Kai Krohn

Title: Innovations and Contributions of Inventor Kai Krohn

Introduction

Kai Krohn is a notable inventor based in Salmentaka, Finland. He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. With a total of 12 patents to his name, Krohn's work has advanced the understanding and treatment of various medical conditions.

Latest Patents

Krohn's latest patents include groundbreaking innovations such as human anti-IFN-α antibodies. These patents provide novel IFN-α binding molecules of human origin, particularly human-derived anti-IFN-α antibodies, as well as IFN-α binding fragments, derivatives, and variants. Additionally, the patents describe pharmaceutical compositions, kits, and methods for use in diagnosis and therapy. Another significant patent involves cDNA encoding a monoclonal anti-IL-32 antibody and methods for its production. This patent also presents novel IL-32 binding molecules of human origin, particularly human anti-IL-32 antibodies, along with IL-32 binding fragments, derivatives, and variants, as well as pharmaceutical compositions, kits, and methods for use in diagnosis and therapy.

Career Highlights

Throughout his career, Krohn has worked with prominent companies in the biotechnology sector, including Immunoqure AG and Fit Biotech Oyj Plc. His work in these organizations has contributed to the advancement of therapeutic solutions and innovative research in the field.

Collaborations

Krohn has collaborated with esteemed colleagues, including Adrian Hayday and Kai Kisand, who have also made significant contributions to the field of immunology and biotechnology.

Conclusion

Kai Krohn's innovative work and numerous patents reflect his dedication to advancing medical science through biotechnology. His contributions have the potential to impact diagnosis and therapy significantly.